New rules mandate that most insurers must now cover the cost. Apretude, Descovy, Truvada, and a generic version of Truvada—often referred to as PrEP—are approved for men at high risk of ...

The patent for branded TDF/emtricitabine (Truvada) has expired, allowing multiple manufacturers to offer inexpensive generic versions that contain the same ingredients. Branded TAF/emtricitabine ...

Mark S. King’s January 10 blog post on his award-winning "My Fabulous Disease" site made me aware of a new, and troubling, ...

The US PrEP market is dominated by Truvada (plus generic versions of the drug in some markets), as well as Gilead's follow-up Descovy (emtricitabine and tenofovir alafenamide), a once-daily oral ...

What Truvada is, is a single pill that’s a combination of two antiretroviral drugs that have a long history of being used as part of a broader combination of therapy for the actual treatment of ...

There are three different products that are currently FDA approved for use as PrEP. These options include two, once-daily oral medications called Truvada (generic versions available), and Descovy. The ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. The litigation ...

The federal government said Gilead failed to compensate the CDC for discovering that Truvada can prevent HIV infections. The lawsuit claimed Gilead "exaggerated" its role in developing the drug's ...